Biodelivery sciences international expects full year 2020 total company net sales of $165 million - $175 million

Biodelivery sciences reports strong third quarter results, raises full year 2019 and provides 2020 net sales expectations.q3 revenue $30.3 million versus refinitiv ibes estimate of $28.3 million.sees fy 2019 sales $105 million to $110 million.provides full year 2020 belbuca net sales expectations of $150 - $160 million.provides full year 2020 total company net sales expectations of $165 - $175 million.qtrly earnings per share $0.00.as of september 30, 2019, cash and cash equivalents were approximately $55.9 million.q3 earnings per share view $-0.02 -- refinitiv ibes data.
BDSI Ratings Summary
BDSI Quant Ranking